Remove tag childrens-boosters
article thumbnail

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

PharmaShots

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

FDA 40
article thumbnail

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

Pfizer’s position will be further boosted with the recent green light for adolescents and 5–11 year olds, as well as the roll out of booster jabs. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Much of the market will depend on how boosters and variants might play out, but Breen believes Covid is a cash cow. “It

Vaccines 128